000 01561 a2200421 4500
005 20250516012241.0
264 0 _c20110408
008 201104s 0 0 eng d
022 _a1473-5628
024 7 _a10.1097/MNM.0b013e32834121cb
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYan, Shu-Xun
245 0 0 _aEffects of technetium-99 methylenediphosphonate on cytokine-induced activation of retro-ocular fibroblasts from patients with Graves' ophthalmopathy.
_h[electronic resource]
260 _bNuclear medicine communications
_cFeb 2011
300 _a142-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCase-Control Studies
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCytokines
_xpharmacology
650 0 4 _aEye
_xpathology
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aGraves Ophthalmopathy
_xmetabolism
650 0 4 _aHLA-DR Antigens
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHyaluronic Acid
_xbiosynthesis
650 0 4 _aIntercellular Adhesion Molecule-1
_xmetabolism
650 0 4 _aMale
650 0 4 _aSkin
_xcytology
650 0 4 _aTechnetium Tc 99m Medronate
_xpharmacology
700 1 _aWang, Ying
700 1 _aPeng, Gui-Jun
700 1 _aLu, Xin-Ping
700 1 _aFu, Yu
773 0 _tNuclear medicine communications
_gvol. 32
_gno. 2
_gp. 142-6
856 4 0 _uhttps://doi.org/10.1097/MNM.0b013e32834121cb
_zAvailable from publisher's website
999 _c20361518
_d20361518